Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect recall alert
The VMD has issued a product defect recall alert for Synulox Lactating Cow Intramammary Suspension.

Recall for Synulox Lactating Cow Intramammary Suspension

The Veterinary Medicines Directorate (VMD has issued a product defect recall alert for Synulox Lactating Cow Intramammary Suspension, manufactured by Zoetis UK.

A statement reads: “Following a recent Good Manufacturing Practice (GMP) inspection of one of the active pharmaceutical ingredient (API) manufacturers for Synulox LC, a statement of non-compliance with GMP has been issued.

“As a precaution, batches of this product containing API that is impacted by this non-compliance statement are being recalled from the market with immediate effect to the end-user (farm) level."

Zoetis UK Ltd is contacting veterinary surgeons and wholesaler dealers to examine inventory and quarantine products subject to this recall.

This issue impacts the following batches that have been placed on the UK market: 

91939702 Synulox LC x 12 syringes 31/01/2021
81950600 Synulox LC x 24 syringes 30/04/2020
81958301 Synulox LC x 24 syringes 30/04/2020
81962601 Synulox LC x 24 syringes 31/05/2020
81966700 Synulox LC x 24 syringes 30/06/2020
81968102 Synulox LC x 24 syringes 30/06/2020
81968300 Synulox LC x 24 syringes 30/06/2020
91927402 Synulox LC x 24 syringes 30/11/2020
91938601 Synulox LC x 24 syringes 31/01/2021
91938700 Synulox LC x 24 syringes 31/01/2021
91954001 Synulox LC x 24 syringes 31/03/2021

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.